Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Trends in and predictors of carbapenem consumption across North American hospitals: results from a multi-center survey by the MAD-ID Research Network.

Rhodes NJ, Wagner JL, Davis SL, Bosso JA, Goff DA, Rybak MJ, Scheetz MH; MAD-ID Research Network.

Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00327-19. doi: 10.1128/AAC.00327-19. [Epub ahead of print]

PMID:
31061154
2.

The Potential for QT Interval Prolongation with Chronic Azithromycin Therapy in Adult Cystic Fibrosis Patients.

Avedissian SN, Rhodes NJ, Ng TMH, Rao AP, Beringer PM.

Pharmacotherapy. 2019 Jun;39(6):718-723. doi: 10.1002/phar.2270. Epub 2019 May 20.

PMID:
31045258
3.

Comparative performance of urinary biomarkers for vancomycin induced kidney injury according to timeline of injury.

Pais GM, Avedissian SN, O'Donnell JN, Rhodes NJ, Lodise TP, Prozialeck WC, Lamar PC, Cluff C, Gulati A, Fitzgerald JC, Downes KJ, Zuppa AF, Scheetz MH.

Antimicrob Agents Chemother. 2019 Apr 15. pii: AAC.00079-19. doi: 10.1128/AAC.00079-19. [Epub ahead of print]

PMID:
30988153
4.

A Review of the Clinical Pharmacokinetics of Polymyxin B.

Avedissian SN, Liu J, Rhodes NJ, Lee A, Pais GM, Hauser AR, Scheetz MH.

Antibiotics (Basel). 2019 Mar 22;8(1). pii: E31. doi: 10.3390/antibiotics8010031. Review.

5.

Diagnostic stewardship of C. difficile testing: a quasi-experimental antimicrobial stewardship study.

Christensen AB, Barr VO, Martin DW, Anderson MM, Gibson AK, Hoff BM, Sutton SH, Widmaier V, Salim AA, Silkaitis C, Qi C, Zembower TR, Postelnick MJ, Rhodes NJ.

Infect Control Hosp Epidemiol. 2019 Mar;40(3):269-275. doi: 10.1017/ice.2018.336. Epub 2019 Feb 21.

PMID:
30786942
6.

Vancomycin Area under the Curve and Acute Kidney Injury: A Meta-analysis.

Aljefri DM, Avedissian SN, Rhodes NJ, Postelnick MJ, Nguyen K, Scheetz MH.

Clin Infect Dis. 2019 Feb 1. doi: 10.1093/cid/ciz051. [Epub ahead of print]

PMID:
30715208
7.

A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime.

Avedissian SN, Pais G, Joshi MD, Rhodes NJ, Scheetz MH.

mSphere. 2019 Jan 30;4(1). pii: e00595-18. doi: 10.1128/mSphere.00595-18.

8.

Understanding the Components, Calculation, and Impact of Monthly and Seasonal Variation of the Standardized Antimicrobial Utilization Ratio (SAAR).

Avedissian SN, Rhodes NJ, Liu J, Aljefri D, Postelnick MJ, Sutton SH, Zembower TR, Martin D, Pais G, Cruce CE, Scheetz MH.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01780-18. doi: 10.1128/AAC.01780-18. Print 2019 Mar.

PMID:
30602510
9.

Cefazolin vs. anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections in acutely ill adult patients: Results of a systematic review and meta-analysis.

Lee BJ, Wang SK, Constantino-Corpuz JK, Apolinario K, Nadler B, McDanel JS, Scheetz MH, Rhodes NJ.

Int J Antimicrob Agents. 2019 Mar;53(3):225-233. doi: 10.1016/j.ijantimicag.2018.11.013. Epub 2018 Nov 23.

PMID:
30476572
10.

Quantifying the importance of active antimicrobial therapy among patients with Gram-negative bloodstream infections: Cefepime as a representative agent.

Miglis C, Rhodes NJ, Liu J, Gener J, Hang E, Scheetz MH.

Int J Antimicrob Agents. 2019 Jan;53(1):95-97. doi: 10.1016/j.ijantimicag.2018.10.004. Epub 2018 Oct 10.

PMID:
30315921
11.

Measuring the impact of varying denominator definitions on standardized antibiotic consumption rates: implications for antimicrobial stewardship programmes.

Avedissian SN, Scheetz MH, Zembower TR, Silkaitis C, Maxwell R, Jenkins C, Postelnick MJ, Sutton SH, Rhodes NJ.

J Antimicrob Chemother. 2018 Oct 1;73(10):2876-2882. doi: 10.1093/jac/dky275.

PMID:
30085084
12.

The authors reply.

Rhodes NJ, Liu J, Lipman J, Roberts JA.

Crit Care Med. 2018 Jul;46(7):e725-e726. doi: 10.1097/CCM.0000000000003164. No abstract available.

PMID:
29912126
13.

Prevalence of a Cefazolin Inoculum Effect Associated with blaZ Gene Types among Methicillin-Susceptible Staphylococcus aureus Isolates from Four Major Medical Centers in Chicago.

Wang SK, Gilchrist A, Loukitcheva A, Plotkin BJ, Sigar IM, Gross AE, O'Donnell JN, Pettit N, Buros A, O'Driscoll T, Rhodes NJ, Bethel C, Segreti J, Charnot-Katsikas A, Singh K, Scheetz MH.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00382-18. doi: 10.1128/AAC.00382-18. Print 2018 Aug.

14.

Polymyxin B Pharmacokinetics in Adult Cystic Fibrosis Patients.

Avedissian S, Miglis C, Kubin CJ, Rhodes NJ, Yin MT, Cremers S, Prickett M, Scheetz MH.

Pharmacotherapy. 2018 May 25. doi: 10.1002/phar.2129. [Epub ahead of print]

PMID:
29800496
15.

Carbapenems vs. alternative β-lactams for the treatment of nosocomial pneumonia: A systematic review and meta-analysis.

O'Donnell JN, Rhodes NJ, Lopez J, Jett R, Scheetz MH.

Int J Antimicrob Agents. 2018 Oct;52(4):451-458. doi: 10.1016/j.ijantimicag.2018.04.011. Epub 2018 Apr 14. Review.

PMID:
29665442
16.

Resistance Trends and Treatment Options in Gram-Negative Ventilator-Associated Pneumonia.

Rhodes NJ, Cruce CE, O'Donnell JN, Wunderink RG, Hauser AR.

Curr Infect Dis Rep. 2018 Mar 6;20(2):3. doi: 10.1007/s11908-018-0609-x. Review.

17.

Population Pharmacokinetics of Polymyxin B in Acutely Ill Adult Patients.

Miglis C, Rhodes NJ, Avedissian SN, Kubin CJ, Yin MT, Nelson BC, Pai MP, Scheetz MH.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e01475-17. doi: 10.1128/AAC.01475-17. Print 2018 Mar.

18.

Population Pharmacokinetics of Intravenous Polymyxin B from Clinical Samples.

Kubin CJ, Nelson BC, Miglis C, Scheetz MH, Rhodes NJ, Avedissian SN, Cremers S, Yin MT.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e01493-17. doi: 10.1128/AAC.01493-17. Print 2018 Mar.

19.

Engaging Pharmacy Students in Research Through Near-Peer Training.

Lee BJ, Rhodes NJ, Scheetz MH, McLaughlin MM.

Am J Pharm Educ. 2017 Nov;81(9):6340. doi: 10.5688/ajpe6340.

20.

Correlation between hospital-level antibiotic consumption and incident health care facility-onset Clostridium difficile infection.

Crew PE, Rhodes NJ, O'Donnell JN, Miglis C, Gilbert EM, Zembower TR, Qi C, Silkaitis C, Sutton SH, Scheetz MH.

Am J Infect Control. 2018 Mar;46(3):270-275. doi: 10.1016/j.ajic.2017.09.015. Epub 2017 Nov 21.

PMID:
29169938
21.

Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis.

Rhodes NJ, Liu J, O'Donnell JN, Dulhunty JM, Abdul-Aziz MH, Berko PY, Nadler B, Lipman J, Roberts JA.

Crit Care Med. 2018 Feb;46(2):236-243. doi: 10.1097/CCM.0000000000002836.

PMID:
29116995
22.

24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.

O'Donnell JN, Rhodes NJ, Lodise TP, Prozialeck WC, Miglis CM, Joshi MD, Venkatesan N, Pais G, Cluff C, Lamar PC, Briyal S, Day JZ, Gulati A, Scheetz MH.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e00416-17. doi: 10.1128/AAC.00416-17. Print 2017 Nov.

23.

Dose, duration, and animal sex predict vancomycin-associated acute kidney injury in preclinical studies.

O'Donnell JN, Rhodes NJ, Miglis CM, Catovic L, Liu J, Cluff C, Pais G, Avedissian S, Joshi MD, Griffin B, Prozialeck W, Gulati A, Lodise TP, Scheetz MH.

Int J Antimicrob Agents. 2018 Feb;51(2):239-243. doi: 10.1016/j.ijantimicag.2017.08.012. Epub 2017 Aug 10. Review.

24.

High-Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin.

Joshi MD, O'Donnell JN, Venkatesan N, Chang J, Nguyen H, Rhodes NJ, Pais G, Chapman RL, Griffin B, Scheetz MH.

Clin Transl Sci. 2017 Nov;10(6):496-502. doi: 10.1111/cts.12484. Epub 2017 Jul 4.

25.

Factors contributing to vancomycin-resistant Enterococcus spp. horizontal transmission events: exploration of the role of antibacterial consumption.

Gilbert EM, Zembower TR, Rhodes NJ, Qi C, Reiner S, Malczynski M, Scheetz MH.

Diagn Microbiol Infect Dis. 2017 Sep;89(1):72-77. doi: 10.1016/j.diagmicrobio.2017.05.014. Epub 2017 Jun 2.

PMID:
28669681
26.

Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens.

Rhodes NJ, Grove ME, Kiel PJ, O'Donnell JN, Whited LK, Rose DT, Jones DR, Scheetz MH.

Int J Antimicrob Agents. 2017 Sep;50(3):482-486. doi: 10.1016/j.ijantimicag.2017.04.008. Epub 2017 Jun 28.

PMID:
28668694
27.

Defining the impact of severity of illness on time above the MIC threshold for cefepime in Gram-negative bacteraemia: a 'Goldilocks' window.

Miglis C, Rhodes NJ, Kuti JL, Nicolau DP, Van Wart SA, Scheetz MH.

Int J Antimicrob Agents. 2017 Sep;50(3):487-490. doi: 10.1016/j.ijantimicag.2017.04.023. Epub 2017 Jun 28.

PMID:
28668683
28.

A Simple Microsoft Excel Method to Predict Antibiotic Outbreaks and Underutilization.

Miglis C, Rhodes NJ, Avedissian SN, Zembower TR, Postelnick M, Wunderink RG, Sutton SH, Scheetz MH.

Infect Control Hosp Epidemiol. 2017 Jul;38(7):860-862. doi: 10.1017/ice.2017.72. Epub 2017 May 3.

PMID:
28464971
29.

Resolution of acyclovir-associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: A case report and review of the literature.

Watson WA, Rhodes NJ, Echenique IA, Angarone MP, Scheetz MH.

J Clin Pharm Ther. 2017 Jun;42(3):350-355. doi: 10.1111/jcpt.12520. Epub 2017 Mar 29. Review.

30.

Correction for Rhodes et al., Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.

Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O'Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e00185-17. doi: 10.1128/AAC.00185-17. Print 2017 Apr. No abstract available.

31.

Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation.

Lee BJ, Rao SN, Wang SK, Lee JY, Lakada IY, Gilbert EM, Barr VO, Postelnick MJ, Sutton SH, Zembower TR, Bolon M, Scheetz MH, Rhodes NJ.

Int J Antimicrob Agents. 2017 May;49(5):650-654. doi: 10.1016/j.ijantimicag.2016.12.021. Epub 2017 Mar 6.

PMID:
28279787
32.

Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing.

O'Donnell JN, Ghossein C, Rhodes NJ, Peng J, Lertharakul T, Pham CK, Scheetz MH.

J Infect Chemother. 2017 May;23(5):326-332. doi: 10.1016/j.jiac.2016.12.011. Epub 2017 Jan 18.

33.

Impact of body mass index on clinical outcomes in patients with gram-negative bacteria bloodstream infections.

Lizza BD, Rhodes NJ, Esterly JS, Toy C, Lopez J, Scheetz MH.

J Infect Chemother. 2016 Oct;22(10):671-6. doi: 10.1016/j.jiac.2016.07.006. Epub 2016 Aug 31.

PMID:
27590417
34.

Radiative neutron capture as a counting technique at pulsed spallation neutron sources: a review of current progress.

Schooneveld EM, Pietropaolo A, Andreani C, Perelli Cippo E, Rhodes NJ, Senesi R, Tardocchi M, Gorini G.

Rep Prog Phys. 2016 Sep;79(9):094301. doi: 10.1088/0034-4885/79/9/094301. Epub 2016 Aug 9.

PMID:
27502571
35.

Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.

Whited L, Grove M, Rose D, Rhodes NJ, Scheetz MH, O'Donnell JN, Neeb J, Thoele K, Jones DR, Lowe C, Moore D, Kiel PJ.

Pharmacotherapy. 2016 Sep;36(9):1003-10. doi: 10.1002/phar.1807. Epub 2016 Sep 6.

PMID:
27496678
36.

Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.

Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O'Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5742-51. doi: 10.1128/AAC.00591-16. Print 2016 Oct. Erratum in: Antimicrob Agents Chemother. 2017 Mar 24;61(4):.

37.

Student Characteristics Associated with Successful Matching to a PGY1 Residency Program.

Phillips JA, McLaughlin MM, Rose C, Gallagher JC, Gettig JP, Rhodes NJ.

Am J Pharm Educ. 2016 Jun 25;80(5):84. doi: 10.5688/ajpe80584.

38.

Prediction of inventory sustainability during a drug shortage.

Rhodes NJ, Gilbert EM, Skoglund E, Esterly JS, Postelnick MJ, McLaughlin MM.

Am J Health Syst Pharm. 2016 Jul 15;73(14):1094-8. doi: 10.2146/ajhp150532.

PMID:
27385704
39.

Days of Therapy and Antimicrobial Days: Similarities and Differences Between Consumption Metrics.

Rhodes NJ, Wagner JL, Gilbert EM, Crew PE, Davis SL, Scheetz MH.

Infect Control Hosp Epidemiol. 2016 Aug;37(8):971-3. doi: 10.1017/ice.2016.109. Epub 2016 May 13.

PMID:
27174570
40.

Investigating the Extremes of Antibiotic Use with an Epidemiologic Framework.

Scheetz MH, Crew PE, Miglis C, Gilbert EM, Sutton SH, O'Donnell JN, Postelnick M, Zembower T, Rhodes NJ.

Antimicrob Agents Chemother. 2016 May 23;60(6):3265-9. doi: 10.1128/AAC.00572-16. Print 2016 Jun.

41.

Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations.

O'Donnell JN, Venkatesan N, Manek M, Rhodes NJ, Scheetz MH.

Am J Health Syst Pharm. 2016 Feb 15;73(4):241-6. doi: 10.2146/ajhp150170.

PMID:
26843502
42.

Pharmacokinetics of centhaquin citrate in a rat model.

O'Donnell JN, Gulati A, Lavhale MS, Sharma SS, Patel AJ, Rhodes NJ, Scheetz MH.

J Pharm Pharmacol. 2016 Jan;68(1):56-62. doi: 10.1111/jphp.12498. Epub 2016 Jan 4.

PMID:
26725913
43.

An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity.

Rhodes NJ, Kuti JL, Nicolau DP, Neely MN, Nicasio AM, Scheetz MH.

J Infect Chemother. 2016 Feb;22(2):78-83. doi: 10.1016/j.jiac.2015.10.009. Epub 2015 Dec 17.

PMID:
26712584
44.

Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival.

Rhodes NJ, Kuti JL, Nicolau DP, Van Wart S, Nicasio AM, Liu J, Lee BJ, Neely MN, Scheetz MH.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1401-10. doi: 10.1128/AAC.01956-15.

45.

Tree-Based Models for Predicting Mortality in Gram-Negative Bacteremia: Avoid Putting the CART before the Horse.

Rhodes NJ, O'Donnell JN, Lizza BD, McLaughlin MM, Esterly JS, Scheetz MH.

Antimicrob Agents Chemother. 2015 Nov 23;60(2):838-44. doi: 10.1128/AAC.01564-15. Print 2016 Feb.

46.

Erratum for Rao et al., treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections.

Rao SN, Rhodes NJ, Lee BJ, Scheetz MH, Hanson AP, Segreti J, Crank CW, Wang SK.

Antimicrob Agents Chemother. 2015 Nov;59(11):7159. doi: 10.1128/AAC.02091-15. No abstract available.

47.

Microbiologic clearance following transition from standard infusion piperacillin-tazobactam to extended-infusion for persistent Gram-negative bacteremia and possible endocarditis: A case report and review of the literature.

D'Agostino C, Rhodes NJ, Skoglund E, Roberts JA, Scheetz MH.

J Infect Chemother. 2015 Oct;21(10):742-6. doi: 10.1016/j.jiac.2015.05.010. Epub 2015 Jun 9.

PMID:
26143049
48.

Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections.

Rao SN, Rhodes NJ, Lee BJ, Scheetz MH, Hanson AP, Segreti J, Crank CW, Wang SK.

Antimicrob Agents Chemother. 2015 Sep;59(9):5232-8. doi: 10.1128/AAC.04677-14. Epub 2015 Jun 15. Erratum in: Antimicrob Agents Chemother. 2015 Nov;59(11):7159.

49.

Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis.

Rhodes NJ, Gardiner BJ, Neely MN, Grayson ML, Ellis AG, Lawrentschuk N, Frauman AG, Maxwell KM, Zembower TR, Scheetz MH.

J Antimicrob Chemother. 2015 Jul;70(7):2068-73. doi: 10.1093/jac/dkv067. Epub 2015 Mar 22.

PMID:
25802286
50.

Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC.

Rhodes NJ, Liu J, McLaughlin MM, Qi C, Scheetz MH.

Diagn Microbiol Infect Dis. 2015 Jun;82(2):165-71. doi: 10.1016/j.diagmicrobio.2015.03.005. Epub 2015 Mar 10.

PMID:
25801780

Supplemental Content

Loading ...
Support Center